William Blair Initiates Coverage on Perrigo (PRGO) with an Outperform
More News related to PRGO
- Perrigo (PRGO) Tops Q3 Views; Raises FY10 Outlook
- Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance
- Perrigo Company Divests Israel Cosmetics Business for 205 Million New Israeli Shekels
- Perrigo (PRGO) Decalres $0.0625 Quarterly Dividend; 0.7% Yield
- Perrigo Company Announces Dividend Increase
William Blair initiates coverage on Perrigo (Nasdaq: PRGO) with an Outperform.
To see more analyst ratings on PRGO Click Here.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products.
Related Categories
New CoverageStocks Mentioned
+0.44Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
